ALLMedicine™ Acute Promyelocytic Leukemia Center
Research & Reviews 2,755 results
https://doi.org/10.1097/MD.0000000000025257
Medicine Zhou X, Li C
Apr 9th, 2021 - Granulocytic sarcoma (GS) is an extramedullary myeloid tumor composed of immature cells of the granulocytic series. It rarely occurs in acute promyelocytic leukemia (APL). No case of long-term survival in an APL patient with recurrent GS has been ...
https://doi.org/10.1124/jpet.121.000537
The Journal of Pharmacology and Experimental Therapeutics; Giansanti M, De Gabrieli A et. al.
Apr 6th, 2021 - Arsenic trioxide (ATO) is an anticancer agent used for the treatment of acute promyelocytic leukemia (APL). However, 5-10% of patients fail to respond or experience disease relapse. Based on poly(ADP-ribose) polymerase 1 (PARP1) involvement in the...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021289
Medicine Xiao M, Qin L et. al.
Mar 31st, 2021 - Acute promyelocytic leukemia (APL) with myelofibrosis (MF) is rare, and only 14 cases have been reported in the literature to date. A 42-year-old woman was admitted to the hospital with easy bruising and excessive bleeding. With the remission of t...
https://doi.org/10.1002/cncr.33477
Cancer Kantarjian HM, Kadia TM et. al.
Mar 18th, 2021 - The unraveling of the pathophysiology of acute myeloid leukemia (AML) has resulted in rapid translation of the information into clinical practice. After more than 40 years of slow progress in AML research, the US Food and Drug Administration has a...
https://doi.org/10.1080/10428194.2021.1894651
Leukemia & Lymphoma; Dhakal P, Lyden E et. al.
Mar 13th, 2021 - Acute promyelocytic leukemia (APL) boasts overall survival (OS) of >90% at 3 years and early mortality of <5% in recent clinical trials. Using a large National Cancer Database, we performed analysis of 7190 adults with APL to determine whether one...
Guidelines 2 results
http://ascopubs.org/doi/10.1200/JCO.18.01468
de Haas, V.
Dec 2nd, 2018 - The College of American Pathologists (CAP) and the American Society of Hematology (ASH) developed an evidence-based guideline on the initial diagnostic work-up of acute leukemia (AL). Because of the relevance of this topic to the ASCO membership,.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161234
Journal of the National Comprehensive Cancer Network : JN... O'Donnell MR, Tallman MS et. al.
Sep 13th, 2013 - These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support the recommendations. The updates described in this article focus on the acute promyelocyt...
Drugs 23 results see all →
Clinicaltrials.gov 2,859 results
https://doi.org/10.1097/MD.0000000000025257
Medicine Zhou X, Li C
Apr 9th, 2021 - Granulocytic sarcoma (GS) is an extramedullary myeloid tumor composed of immature cells of the granulocytic series. It rarely occurs in acute promyelocytic leukemia (APL). No case of long-term survival in an APL patient with recurrent GS has been ...
https://doi.org/10.1124/jpet.121.000537
The Journal of Pharmacology and Experimental Therapeutics; Giansanti M, De Gabrieli A et. al.
Apr 6th, 2021 - Arsenic trioxide (ATO) is an anticancer agent used for the treatment of acute promyelocytic leukemia (APL). However, 5-10% of patients fail to respond or experience disease relapse. Based on poly(ADP-ribose) polymerase 1 (PARP1) involvement in the...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021289
Medicine Xiao M, Qin L et. al.
Mar 31st, 2021 - Acute promyelocytic leukemia (APL) with myelofibrosis (MF) is rare, and only 14 cases have been reported in the literature to date. A 42-year-old woman was admitted to the hospital with easy bruising and excessive bleeding. With the remission of t...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=844941d4-f557-42cf-b7fa-5bd7574925f6
Mar 28th, 2021 - Tretinoin capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant), characterized by the presence of the t(15;17) transloc...
https://doi.org/10.1002/cncr.33477
Cancer Kantarjian HM, Kadia TM et. al.
Mar 18th, 2021 - The unraveling of the pathophysiology of acute myeloid leukemia (AML) has resulted in rapid translation of the information into clinical practice. After more than 40 years of slow progress in AML research, the US Food and Drug Administration has a...
News 77 results
https://decisionpoint.medscape.com/oncology/viewarticle/936167
Sep 17th, 2020 - This transcript has been edited for clarity. Differentiation syndrome is a frequent complication while patients have active acute promyelocytic leukemia (APL). First of all, we need to mention that the diagnosis of differentiation syndrome is base...
https://www.medscape.com/viewarticle/934124
Jul 16th, 2020 - The estimated one third of patients with acute promyelocytic leukemia (APL) who are older than 60 years of age now enjoy a notably better prognosis than in years past, thanks to the introduction of all-trans retinoic acid (ATRA) and arsenic trioxi...
https://www.staging.medscape.com/viewarticle/917519
Aug 29th, 2019 - While leading his team on a hospital round, Joshua F. Zeidner, MD, saw a note recommending that arsenic trioxide (Trisenox, Teva) should be temporarily discontinued in a 44-year-old woman with acute promyelocytic leukemia (APL). The recommendation...
https://www.medscape.com/viewarticle/917519
Aug 29th, 2019 - While leading his team on a hospital round, Joshua F. Zeidner, MD, saw a note recommending that arsenic trioxide (Trisenox, Teva) should be temporarily discontinued in a 44-year-old woman with acute promyelocytic leukemia (APL). The recommendation...
https://www.mdedge.com/hematology-oncology/article/190803/leukemia-myelodysplasia-transplantation/fda-approves-generic-drugs-apl?channel=50519
HT Staff
Nov 16th, 2018 - Photo from Business Wire Fresenius Kabi’s arsenic trioxide The U. S.